New 2026 cholesterol guideline puts more focus on lipoprotein(a): What it could mean for your heart risk

A new U.S. cholesterol guideline is putting more attention on something many people have never heard of: lipoprotein(a), often shortened to Lp(a).

The practical takeaway is simple. If heart disease runs in your family, or if your personal risk seems higher than your usual cholesterol numbers suggest, it may be worth asking a clinician whether a one-time Lp(a) blood test makes sense for you. But this is not a message that everyone needs urgent extra testing, and it does not replace the basics of heart prevention.

The updated 2026 dyslipidemia guideline from the American College of Cardiology, the American Heart Association, and partner groups replaces the 2018 cholesterol guideline. One of its biggest shifts is that it looks beyond standard LDL, often called bad cholesterol, and gives clinicians more tools to refine a person’s overall cardiovascular risk.

What changed in the 2026 cholesterol guideline

The new guideline broadens cholesterol care from a narrower focus on LDL alone to a fuller look at other blood particles and risk markers that may matter for some patients. That includes lipoprotein(a), selective apolipoprotein B testing, and coronary artery calcium scoring in certain situations.

In other words, the guideline is not saying LDL no longer matters. It still matters a great deal. Instead, the update adds nuance. For some people, a routine cholesterol panel does not tell the whole story, especially when family history or other clues suggest inherited risk.

That matters because heart disease remains the leading cause of death in the United States, according to the CDC. Better risk assessment can help some patients and clinicians make clearer decisions earlier, before a heart attack or stroke happens.

What lipoprotein(a) is and why many people have never heard of it

Lipoprotein(a) is a blood particle related to LDL cholesterol, but it is not the same thing. MedlinePlus describes it as a type of lipoprotein that can help refine heart and blood vessel risk beyond what a routine cholesterol test shows.

Most people have never heard of Lp(a) because it usually is not included in a standard lipid panel. If you have had cholesterol checked in the past, that does not necessarily mean Lp(a) was measured.

Another reason it gets less attention is that Lp(a) is mostly inherited. It tends to stay fairly stable over time and is not usually changed very much by diet, exercise, or weight loss alone. Those habits are still crucial for heart health, but they do not fully explain why one person’s Lp(a) is high and another person’s is not.

Who may want to ask about a one-time test

The guideline puts emphasis on considering at least one lifetime Lp(a) measurement, rather than repeated routine testing for everyone.

People who may be most likely to benefit from asking about it include:

people with a family history of early heart disease or stroke
people whose personal or family history seems riskier than their routine cholesterol numbers suggest
people with persistent cholesterol-related concerns despite treatment discussions based on standard lab results
people who have had cardiovascular problems that seem hard to explain from usual risk factors alone

It may also come up when a patient and clinician are unsure how aggressive to be with prevention, such as whether to start or intensify cholesterol-lowering treatment, or whether other testing might help clarify risk.

What an Lp(a) result can and cannot tell you

This is where context matters most.

An Lp(a) result can help refine risk. It may help explain why cardiovascular disease appears in some families, or why a person’s risk seems higher than expected from a routine cholesterol panel alone. It can also help frame a more informed discussion about prevention.

But an Lp(a) result cannot diagnose blocked arteries by itself. It cannot tell you that a heart attack is about to happen. It does not, on its own, prove that you need a specific drug or procedure.

It is also not a stand-alone screening answer. Lp(a) is one piece of the puzzle alongside age, blood pressure, diabetes, smoking, family history, LDL levels, and sometimes other tools such as coronary artery calcium scoring.

Interpretation can be tricky because labs may report Lp(a) in different units, and the meaning of a result depends on the rest of your health picture. That is one reason the guideline frames it as part of risk assessment, not as a single test that settles everything.

How Lp(a) fits with standard cholesterol treatment and prevention

For most people, the foundation of heart prevention does not change.

Lowering LDL when appropriate still matters. So does controlling blood pressure, managing diabetes, not smoking, staying physically active, eating a heart-healthy diet, getting enough sleep, and taking prescribed medicines as directed.

The new guideline also brings back more emphasis on treatment goals for LDL and non-HDL cholesterol, highlights selective apolipoprotein B measurement for some patients, and expands the use of coronary artery calcium scoring in certain risk discussions. Those changes all point in the same direction: more personalized prevention, not less.

That means a high Lp(a) result usually does not lead to a single automatic next step. More often, it can strengthen the case for paying closer attention to the basics that already reduce heart risk, especially LDL lowering and other proven prevention measures.

What this means for readers

If heart disease runs in your family, especially at younger ages, ask whether a one-time Lp(a) test is worth discussing at a routine visit.

If your standard cholesterol numbers have looked acceptable, remember that routine panels do not always capture inherited risk markers like Lp(a).

And if you do have Lp(a) measured, treat the result as useful information, not a diagnosis. The goal is not to chase a single lab number. The goal is to understand your overall risk well enough to make smarter prevention decisions.

Questions to ask at a routine visit

Given my family history, would a one-time Lp(a) test be useful for me?
Was Lp(a) ever included in my past blood work, or would this be a separate test?
If my Lp(a) is elevated, how would that change my overall heart risk discussion?
Should we focus more on LDL lowering or any other proven prevention steps?
Would any other risk tools, such as coronary artery calcium scoring, make sense in my situation?

The bottom line: the 2026 guideline does not turn Lp(a) into the new center of heart care. It simply gives it a more defined place in the conversation. For the right patient, that one extra piece of information may help make prevention more personal and more precise.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.